e-Article
Effects of CYP3A Inhibition, CYP3A Induction, and Gastric Acid Reduction on the Pharmacokinetics of Ripretinib, a Switch Control KIT Tyrosine Kinase Inhibitor
Document Type
Article
Author
Source
In: Clinical Pharmacology in Drug Development . (Clinical Pharmacology in Drug Development, October 2022, 11(10):1165-1176)
Subject
Language
English
ISSN
21607648
2160763X
2160763X